Rithm Capital Corp. merger with Paramount Group, Inc.

Rithm Capital Corp. announced the completion of its merger with Paramount Group, Inc. on December 19, 2025. The unaudited pro forma condensed combined financial information details the merger terms, including cash consideration of $6.60 per share for Paramount common stock and operating partnership units.

Capstone Green Energy Reports Strong Q3 Results

Capstone Green Energy Holdings, Inc. reported strong financial results for its third quarter of fiscal year 2026, ended December 31, 2025. The company announced a 33% increase in revenue to $26.8 million and achieved its second consecutive quarter of positive net income, reporting $1.2 million.

AEP Reports 2025 Results and Reaffirms Growth Outlook

American Electric Power (AEP) reported its fourth-quarter and full-year 2025 financial results, including GAAP earnings of $6.70 per share and operating earnings of $5.97 per share for the full year. The company reaffirmed its 2026 operating earnings guidance and long-term growth rate, and announced significant increases in anticipated load growth and potential investment opportunities.

Semnur Pharmaceuticals - Jaisim Shah Separation Agreement

Semnur Pharmaceuticals has filed a separation agreement with Jaisim Shah, detailing the terms of his departure as an employee and director. The agreement outlines continued base salary payments for six months and a 90-day extension to exercise vested stock options.

Select Medical Holdings Corporation Announces Q4 2025 Results and 2026 Outlook

Select Medical Holdings Corporation announced its financial results for the fourth quarter and full year ended December 31, 2025, along with its 2026 business outlook and a cash dividend declaration. The company reported increased revenue for both periods and significant improvements in income from continuing operations compared to the prior year.

Bryan Jones Separation Agreement from Aardvark Therapeutics

Aardvark Therapeutics, Inc. has entered into a separation agreement with Bryan Jones, effective February 9, 2026. Jones will resign from executive officer positions but will serve as CEO of a subsidiary and provide transition services for nine months. The agreement outlines severance benefits contingent on compliance with its terms.

Astera Labs Transition Services Agreement for CFO Resignation

Astera Labs has entered into a Transition Services Agreement with its Chief Financial Officer, Mike Tate, following his resignation. The agreement outlines his transition from CFO to an employee strategic advisor role from March 2, 2026, to September 1, 2026, with continued salary, benefits, and equity vesting.

Workday Executive Separation Agreement with Carl Eschenbach

Workday, Inc. has entered into an Executive Separation Agreement and General Release of Claims with its former CEO, Carl Eschenbach, effective February 6, 2026. The agreement details separation compensation, including cash severance of $2,625,000 and additional bonus severance of $941,463, along with COBRA payments and equity acceleration.

Public's Financial Assets Portfolio Increased in Q4 2025

The Bank of Israel reported that the public's financial assets portfolio increased by approximately NIS 287.4 billion (4.2 percent) in the fourth quarter of 2025, reaching NIS 7.2 trillion. For the full year 2025, the portfolio grew by 15.5 percent, driven primarily by increases in equities and cash/deposits.

GBC Registered Trademark TM78613348 for Medical Services

The USPTO has registered trademark TM78613348 for GBC, covering medical services and consultations. The trademark was registered on March 28, 2026, with a filing date of April 21, 2005.